Fig. 1From: Anticancer drug R&D landscape in ChinaPhase 1 oncology pipeline, targets, and studied cancer types. a Overall phase 1 pipeline. b Cell therapy pipeline. c Top 30 targets in the phase 1 pipeline. d Most studied cancer types in phase 1 trials and changes relative to 2017Back to article page